{
    "additionDate": "2019-11-14T18:27:12Z",
    "biotoolsCURIE": "biotools:RESULTSCellMinerCDB",
    "biotoolsID": "RESULTSCellMinerCDB",
    "confidence_flag": "medium",
    "credit": [
        {
            "email": "pommier@nih.gov",
            "name": "Yves Pommier",
            "typeEntity": "Person"
        }
    ],
    "description": "> MEDIUM CONFIDENCE! | > COMMON LINK WITH (PUB. & NAME DIFFERENT) bio.tools/CellMinerCDB (DISCOVER.NCI.NIH.GOV/cellminercdb), bio.tools/mammalian_gene_collection (NCI.NIH.GOV), bio.tools/rcellminer (NCI.NIH.GOV/cellminer), bio.tools/cgap (NCI.NIH.GOV), bio.tools/pid (NCI.NIH.GOV) | > CORRECT NAME OF TOOL COULD ALSO BE 'DESIGN:CellMinerCDB', 'indenoisoquinolines', 'LMP400 olaparib', 'LMP400' | The Indenoisoquinoline TOP1 Inhibitors Selectively Target Homologous Recombination-Deficient and Schlafen 11-Positive Cancer Cells and Synergize with Olaparib | CellMiner Cross Database (CellMinerCDB) is the first web application to allow translational researchers to conduct analyses across all major cancer cell line pharmacogenomic data sources from NCI-DTP NCI-60, Sanger GDSC, and Broad CCLE/CTRP | Skip over navigation CellMiner NCI-60 NCI/DCTD/DTP",
    "editPermission": {
        "type": "public"
    },
    "homepage": "http://discover.nci.nih.gov/cellminercdb",
    "lastUpdate": "2019-11-14T18:27:12Z",
    "name": "RESULTS:CellMinerCDB",
    "owner": "Pub2Tools",
    "publication": [
        {
            "doi": "10.1158/1078-0432.CCR-19-0419",
            "pmcid": "PMC6801079",
            "pmid": "31409613"
        }
    ],
    "topic": [
        {
            "term": "Biomarkers",
            "uri": "http://edamontology.org/topic_3360"
        },
        {
            "term": "Pharmacogenomics",
            "uri": "http://edamontology.org/topic_0208"
        },
        {
            "term": "Oncology",
            "uri": "http://edamontology.org/topic_2640"
        }
    ]
}